Scientific Literature Search

Open access

Hippocampal subfield diffusion abnormalities in Parkinson's disease with mild cognitive impairment: a volumetric and diffusion MRI study.

Chen Y, Peng L, Hu Q, Zhao Z, Xu B.

Front Aging Neurosci · 2026-09-09

DOI: 10.3389/fnagi.2026.1946629PMID: 42780862

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Baseline mood and non-motor symptom burden are associated with cognitive progression in Parkinson's disease: an interpretable follow-up cohort analysis with separate neuroimaging, molecular, and digital analyses in independent samples.

Ren J, Ren J, Yu H, Gao H, Wang K, Xu C.

Front Artif Intell · 2026-09-07

DOI: 10.3389/frai.2026.1924525PMID: 42769173

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian α-synucleinopathies: a systematic review.

Garrou F, Leva L, Sacchetti GM, De Natale ER, Tondo G, Comi C.

J Neurol · 2026-09-07

DOI: 10.1007/s00415-026-14123-2PMID: 42704496

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Nigrostriatal free-water imaging and volumetry outperform quantitative T1 in neurodegenerative Parkinson syndromes.

Schröter N, Both L, Jost WH, Rijntjes M, Kellner E, Hosp JA, Groppa S, Wiendl H, Reisert M, Urbach H, Rau A.

Parkinsonism Relat Disord · 2026-09-07

DOI: 10.1016/j.parkreldis.2026.108974PMID: 42748855

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.

Chishiki Y, Tagai K, Kataoka Y, Goto R, Osawa K, Oyama A, Matsumoto H, Ichihashi M, Momota Y, Kamada T, Seki C, Matsuoka K, Hirata K, Kurose S, Moriguchi S, Komatsu Y, Kato H, Yamamoto Y, Nakano Y, Hirano S, Shinotoh H, Shimada H, Tokuda T, Kawamura K, Zhang MR, Takahata K, Higuchi M, Endo H.

Mov Disord · 2026-09-04

DOI: 10.1002/mds.70468PMID: 42696070

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Protocol to quantify LRRK2-mediated Rab10 phosphorylation using high-content imaging.

Masotti B, Lorenzon P, Covello G, Greggio E.

STAR Protoc · 2026-09-04

DOI: 10.1016/j.xpro.2026.104819PMID: 42696457

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Data-driven subtyping of Parkinson's disease using MRI: current insights, challenges, and future directions.

Vijayakumari AA, Sakaie KE, Fernandez HH, Walter BL.

Front Aging Neurosci · 2026-09-03

DOI: 10.3389/fnagi.2026.1819248PMID: 42756554

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Distinct Spatiotemporal Patterns of Dopaminergic and Metabolic Imaging in De Novo Parkinson's Disease.

Lee JH, Na HK, Ahn SJ, Park M, Bio J, Lee JH, Ryu YH, Yoo HS, Lyoo CH.

Mov Disord · 2026-09-03

DOI: 10.1002/mds.70498PMID: 42693703

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Exploratory imaging in SWEDD: Insights from dopaminergic PET, synaptic density PET, and volumetric MRI.

Ebrahimian Sadabad F, Volpi T, Tinaz S, Honhar P, Colon L, Mayeli M, Pittman B, Naganawa M, Dias M, Angarita GA, Comley R, Carson RE, Finnema SJ, Matuskey D.

Parkinsonism Relat Disord · 2026-09-02

DOI: 10.1016/j.parkreldis.2026.108960PMID: 42691866

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Increased Binding of [<sup>18</sup>F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson's Disease Brain.

Mukherjee J, Karim F, Ngo A, Liang C, Serrano GE, Beach TG.

Synapse · 2026-09-01

DOI: 10.1002/syn.70053PMID: 42544822

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Magnetic resonance imaging markers predict disease progression in early-stage multiple system atrophy: a 2-year prospective cohort study.

Zhang L, Lin J, Li C, Wei Q, Ou R, Yang T, Xiao Y, Jiang Q, Chen X, Zhao B, Shang H.

J Gerontol A Biol Sci Med Sci · 2026-09-01

DOI: 10.1093/gerona/glag194PMID: 42554316

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Erratum: Comparative Performance of Susceptibility Map-Weighted MRI According to the Acquisition Planes in the Diagnosis of Neurodegenerative Parkinsonism.

Lee S, Suh CH, Jo S, Chung SJ, Heo H, Shim WH, Lee J, Kim HS, Kim SJ, Kim EY.

Korean J Radiol · 2026-09-01

DOI: 10.3348/kjr.2026.1411PMID: 42683646

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

3.473 articles found

Hippocampal subfield diffusion abnormalities in Parkinson's disease with mild cognitive impairment: a volumetric and diffusion MRI study.

Baseline mood and non-motor symptom burden are associated with cognitive progression in Parkinson's disease: an interpretable follow-up cohort analysis with separate neuroimaging, molecular, and digital analyses in independent samples.

Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian α-synucleinopathies: a systematic review.

Nigrostriatal free-water imaging and volumetry outperform quantitative T1 in neurodegenerative Parkinson syndromes.

Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.

Protocol to quantify LRRK2-mediated Rab10 phosphorylation using high-content imaging.

Data-driven subtyping of Parkinson's disease using MRI: current insights, challenges, and future directions.

Distinct Spatiotemporal Patterns of Dopaminergic and Metabolic Imaging in De Novo Parkinson's Disease.

Exploratory imaging in SWEDD: Insights from dopaminergic PET, synaptic density PET, and volumetric MRI.

Increased Binding of [<sup>18</sup>F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus-Subiculum of Postmortem Human Parkinson's Disease Brain.

Magnetic resonance imaging markers predict disease progression in early-stage multiple system atrophy: a 2-year prospective cohort study.

Erratum: Comparative Performance of Susceptibility Map-Weighted MRI According to the Acquisition Planes in the Diagnosis of Neurodegenerative Parkinsonism.

Filters